Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2005-09-22

Last Posted Date: 2013-06-20

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 15

Registration Number: NCT00217503

Locations: 🇺🇸
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Phase 1

Completed

Conditions: Stage III Melanoma
Stage IV Melanoma
Stage IV Renal Cell Cancer
Recurrent Melanoma
Recurrent Renal Cell Cancer

Interventions: Biological: recombinant interferon alfa-2b
Drug: amifostine/azacitidine

First Posted Date: 2005-09-22

Last Posted Date: 2013-05-03

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 42

Registration Number: NCT00217542

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Completed

Conditions: Type 1 Diabetes Mellitus

First Posted Date: 2005-09-21

Last Posted Date: 2016-05-13

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 100

Registration Number: NCT00212329

Locations: 🇺🇸
Childrens Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Barbara Davis Center for Childhood Diabetes, Denver, Colorado, United States

and more 11 locations

Adolescent Weight Management Study

Not Applicable

Completed

Conditions: Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food
Protocol #1:Behavioral Therapy + Placebo or Sibutramine

First Posted Date: 2005-09-21

Last Posted Date: 2015-04-17

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 120

Registration Number: NCT00212173

Conservative Treatment of Postprostatectomy Incontinence

Not Applicable

Completed

Conditions: Urinary Incontinence

Interventions: Other: No Treatment
Behavioral: Behavioral Therapy
Device: Pelvic Floor Electrical Stimulation
Behavioral: Biofeedback

First Posted Date: 2005-09-21

Last Posted Date: 2016-04-11

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 208

Registration Number: NCT00212264

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Exercise Training in Type 2 Diabetes and Hypertension

Phase 4

Completed

Conditions: Type 2 Diabetes
Hypertension

Interventions: Behavioral: Exercise training for 6 months

First Posted Date: 2005-09-21

Last Posted Date: 2013-01-23

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 115

Registration Number: NCT00212303

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)

Completed

Conditions: Helicobacter Infections
Gastritis
Peptic Ulcer

First Posted Date: 2005-09-21

Last Posted Date: 2010-01-13

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 755

Registration Number: NCT00212225

Locations: 🇺🇸
Miami Children's Hospital; Division of Pediatric Gastroenterology, Miami, Florida, United States
🇺🇸
Case Western Reserve University; Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
🇺🇸
Emory University School of Medicine; Emory Children's Center, Atlanta, Georgia, United States

Enhanced Internet Behavior Therapy for Treating Obesity

Not Applicable

Completed

Conditions: Obesity

First Posted Date: 2005-09-21

Last Posted Date: 2010-03-18

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 100

Registration Number: NCT00212238

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Effectiveness of Brief Counseling for Weight Management

Phase 4

Completed

Conditions: 1. Obesity

First Posted Date: 2005-09-21

Last Posted Date: 2010-03-18

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 246

Registration Number: NCT00212199

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes

Phase 4

Completed

Conditions: Insulin Resistance
Type 2 Diabetes Mellitus

First Posted Date: 2005-09-21

Last Posted Date: 2010-02-15

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 140

Registration Number: NCT00212290

Locations: 🇺🇸
VA Puget Sound Health Care System (American Lake Campus), Tacoma, Washington, United States
🇺🇸
VA Puget Sound Health Care System (Seattle Campus), Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy